• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利拉鲁肽在瘦人和肥胖者中脑(中枢)与胰腺作用的不一致性

Discordance Between Central (Brain) and Pancreatic Action of Exenatide in Lean and Obese Subjects.

作者信息

Eldor Roy, Daniele Giuseppe, Huerta Claudia, Al-Atrash Mariam, Adams John, DeFronzo Ralph, Duong Timothy, Lancaster John, Zirie Mahmoud, Jayyousi Amin, Abdul-Ghani Muhammad

机构信息

Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, TX.

Imaging Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX.

出版信息

Diabetes Care. 2016 Oct;39(10):1804-10. doi: 10.2337/dc15-2706. Epub 2016 Aug 3.

DOI:10.2337/dc15-2706
PMID:27489336
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5864097/
Abstract

OBJECTIVE

This study examined the effect of exenatide on brain activity measured by functional (f)MRI and on insulin secretion in lean and obese normal-glucose-tolerant individuals.

RESEARCH DESIGN AND METHODS

The brain fMRI signal in response to high-calorie-content food pictures was measured with and without intravenous exenatide infusion in 10 lean and 10 obese healthy volunteers. Insulin secretion was measured with a two-step (+100 and +200 mg/dL) hyperglycemic clamp with exenatide and with saline infusion.

RESULTS

The brain fMRI signal in response to food pictures in amygdala, insula, hippocampus, and frontal cortex was significantly greater in obese versus lean individuals. Intravenous exenatide significantly inhibited the fMRI signal in response to food pictures in obese individuals but did not affect the brain fMRI signal in lean subjects. Conversely, exenatide infusion caused an 18.5-fold increase in insulin secretion in lean individuals compared with an 8.8-fold increase in obese subjects. No significant correlation was observed between inhibition of the brain fMRI signal and increase in insulin secretion during exenatide infusion.

CONCLUSIONS

Exenatide causes greater augmentation in insulin secretion in lean compared with obese individuals but inhibits the brain response to food pictures only in obese individuals.

摘要

目的

本研究检测了艾塞那肽对通过功能磁共振成像(fMRI)测量的脑活动以及对体重正常和肥胖的糖耐量正常个体胰岛素分泌的影响。

研究设计与方法

在10名体重正常和10名肥胖的健康志愿者中,分别在静脉输注艾塞那肽前后测量其对高热量食物图片产生反应时的脑fMRI信号。采用两步法(+100和+200mg/dL)高血糖钳夹技术,分别在输注艾塞那肽和生理盐水时测量胰岛素分泌情况。

结果

与体重正常个体相比,肥胖个体杏仁核、脑岛、海马体和额叶皮质对食物图片产生反应时的脑fMRI信号显著增强。静脉注射艾塞那肽显著抑制了肥胖个体对食物图片产生反应时的fMRI信号,但对体重正常个体的脑fMRI信号无影响。相反,与肥胖个体增加8.8倍相比,输注艾塞那肽使体重正常个体的胰岛素分泌增加了18.5倍。在输注艾塞那肽期间,未观察到脑fMRI信号抑制与胰岛素分泌增加之间存在显著相关性。

结论

与肥胖个体相比,艾塞那肽使体重正常个体的胰岛素分泌增加幅度更大,但仅抑制肥胖个体对食物图片的脑反应。

相似文献

1
Discordance Between Central (Brain) and Pancreatic Action of Exenatide in Lean and Obese Subjects.利拉鲁肽在瘦人和肥胖者中脑(中枢)与胰腺作用的不一致性
Diabetes Care. 2016 Oct;39(10):1804-10. doi: 10.2337/dc15-2706. Epub 2016 Aug 3.
2
Acute effects of the glucagon-like peptide-1 receptor agonist, exenatide, on blood pressure and heart rate responses to intraduodenal glucose infusion in type 2 diabetes.胰高血糖素样肽-1受体激动剂艾塞那肽对2型糖尿病患者十二指肠内输注葡萄糖时血压和心率反应的急性影响。
Diab Vasc Dis Res. 2017 Jan;14(1):59-63. doi: 10.1177/1479164116666761. Epub 2016 Oct 20.
3
Glucagon-Like Peptide-1 Receptor Agonist Differentially Affects Brain Activation in Response to Visual Food Cues in Lean and Obese Individuals with Type 2 Diabetes Mellitus.胰高血糖素样肽-1 受体激动剂在 2 型糖尿病肥胖和非肥胖个体对视觉食物线索的反应中对大脑激活的影响不同。
Diabetes Metab J. 2020 Apr;44(2):248-259. doi: 10.4093/dmj.2019.0018. Epub 2019 Nov 4.
4
The GLP-1 mimetic exenatide potentiates insulin secretion in healthy cats.GLP-1 类似物 exenatide 增强健康猫的胰岛素分泌。
Domest Anim Endocrinol. 2011 Jul;41(1):42-9. doi: 10.1016/j.domaniend.2011.03.001. Epub 2011 Apr 6.
5
Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome.艾塞那肽单次给药对 Prader-Willi 综合征成人的食欲、肠道激素和葡萄糖稳态的影响。
J Clin Endocrinol Metab. 2011 Aug;96(8):E1314-9. doi: 10.1210/jc.2011-0038. Epub 2011 Jun 1.
6
A Placebo-Controlled Study on the Effects of the Glucagon-Like Peptide-1 Mimetic, Exenatide, on Insulin Secretion, Body Composition and Adipokines in Obese, Client-Owned Cats.一项关于胰高血糖素样肽-1类似物艾塞那肽对肥胖家养猫胰岛素分泌、身体成分和脂肪因子影响的安慰剂对照研究。
PLoS One. 2016 May 2;11(5):e0154727. doi: 10.1371/journal.pone.0154727. eCollection 2016.
7
Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study.艾塞那肽与西他列汀对餐后血糖、胰岛素和胰高血糖素分泌、胃排空及热量摄入的影响:一项随机交叉研究。
Curr Med Res Opin. 2008 Oct;24(10):2943-52. doi: 10.1185/03007990802418851. Epub 2008 Sep 10.
8
Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia.静脉输注艾塞那肽(合成艾塞那肽-4)对低血糖期间葡萄糖依赖性胰岛素分泌及对抗调节的影响。
Diabetes. 2004 Sep;53(9):2397-403. doi: 10.2337/diabetes.53.9.2397.
9
Leptin restores the insulinotropic effect of exenatide in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and high-fat diet.在由链脲佐菌素和高脂饮食诱导的肥胖增加的2型糖尿病小鼠模型中,瘦素可恢复艾塞那肽的促胰岛素分泌作用。
Am J Physiol Endocrinol Metab. 2014 Oct 15;307(8):E712-9. doi: 10.1152/ajpendo.00272.2014. Epub 2014 Aug 26.
10
GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans.GLP-1 受体激活调节人类的食欲和奖励相关脑区。
Diabetes. 2014 Dec;63(12):4186-96. doi: 10.2337/db14-0849. Epub 2014 Jul 28.

引用本文的文献

1
Glucagon-like Peptide-1 Receptor Agonists: A New Frontier in Treating Alcohol Use Disorder.胰高血糖素样肽-1受体激动剂:治疗酒精使用障碍的新前沿。
Brain Sci. 2025 Jun 29;15(7):702. doi: 10.3390/brainsci15070702.
2
Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial.替尔泊肽对超重或肥胖成年人摄食行为的影响:一项为期6周的随机1期试验。
Nat Med. 2025 Jun 24. doi: 10.1038/s41591-025-03774-9.
3
Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agent in psychiatric and neurodevelopmental conditions: evidence from a drug target Mendelian randomization.探索胰高血糖素样肽-1受体激动剂作为精神和神经发育疾病潜在疾病修饰剂:来自药物靶点孟德尔随机化的证据
BMC Psychiatry. 2025 May 14;25(1):484. doi: 10.1186/s12888-025-06914-0.
4
Does semaglutide reduce alcohol intake in Danish patients with alcohol use disorder and comorbid obesity? Trial protocol of a randomised, double-blinded, placebo-controlled clinical trial (the SEMALCO trial).司美格鲁肽能否减少丹麦酒精使用障碍合并肥胖患者的酒精摄入量?一项随机、双盲、安慰剂对照临床试验的试验方案(SEMACLO试验)。
BMJ Open. 2025 Jan 8;15(1):e086454. doi: 10.1136/bmjopen-2024-086454.
5
Effects of the glucagon-like peptide-1 receptor agonist dulaglutide on sexuality in healthy men: a randomised, double-blind, placebo-controlled crossover study.胰高血糖素样肽-1 受体激动剂度拉鲁肽对健康男性性功能的影响:一项随机、双盲、安慰剂对照交叉研究。
EBioMedicine. 2024 Sep;107:105284. doi: 10.1016/j.ebiom.2024.105284. Epub 2024 Sep 4.
6
Effects of dulaglutide on alcohol consumption during smoking cessation.度拉糖肽对戒烟期间饮酒的影响。
JCI Insight. 2023 Nov 22;8(22):e170419. doi: 10.1172/jci.insight.170419.
7
Neuroimaging Investigations of Obesity: a Review of the Treatment of Sex from 2010.神经影像学在肥胖研究中的应用:2010 年以来对性别的治疗作用的综述。
Curr Obes Rep. 2023 Jun;12(2):163-174. doi: 10.1007/s13679-023-00498-0. Epub 2023 Mar 18.
8
Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial.一项随机、安慰剂对照临床试验研究了每周一次给予 exenatide 治疗酒精使用障碍。
JCI Insight. 2022 Oct 10;7(19):e159863. doi: 10.1172/jci.insight.159863.
9
GLP-1 physiology informs the pharmacotherapy of obesity.GLP-1 生理学为肥胖症的药物治疗提供了依据。
Mol Metab. 2022 Mar;57:101351. doi: 10.1016/j.molmet.2021.101351. Epub 2021 Oct 6.
10
Berberine is an insulin secretagogue targeting the KCNH6 potassium channel.小檗碱是一种作用于 KCNH6 钾通道的胰岛素促分泌剂。
Nat Commun. 2021 Sep 23;12(1):5616. doi: 10.1038/s41467-021-25952-2.

本文引用的文献

1
Type 2 diabetes mellitus.2 型糖尿病。
Nat Rev Dis Primers. 2015 Jul 23;1:15019. doi: 10.1038/nrdp.2015.19.
2
Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes.内源性胰高血糖素样肽-1介导2型糖尿病患者餐后中枢奖赏和饱腹感区域激活的降低。
Diabetologia. 2015 Dec;58(12):2688-98. doi: 10.1007/s00125-015-3754-x. Epub 2015 Sep 18.
3
Exenatide Regulates Cerebral Glucose Metabolism in Brain Areas Associated With Glucose Homeostasis and Reward System.艾塞那肽调节与葡萄糖稳态和奖赏系统相关脑区的脑葡萄糖代谢。
Diabetes. 2015 Oct;64(10):3406-12. doi: 10.2337/db14-1718. Epub 2015 Jun 26.
4
Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon-like peptide-1 receptor activation in humans.在人类中,胰高血糖素样肽-1受体激活会改变大脑奖励系统对美味食物预期和食用的反应。
Diabetes Obes Metab. 2015 Sep;17(9):878-86. doi: 10.1111/dom.12506. Epub 2015 Jul 22.
5
GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans.GLP-1 受体激活调节人类的食欲和奖励相关脑区。
Diabetes. 2014 Dec;63(12):4186-96. doi: 10.2337/db14-0849. Epub 2014 Jul 28.
6
Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS.胰高血糖素样肽 1 对食欲和体重的影响:重点关注中枢神经系统。
J Endocrinol. 2014 Mar 7;221(1):T1-16. doi: 10.1530/JOE-13-0414. Print 2014 Apr.
7
The regulation of food intake by the gut-brain axis: implications for obesity.肠道-脑轴对摄食的调节:肥胖的影响。
Int J Obes (Lond). 2013 May;37(5):625-33. doi: 10.1038/ijo.2012.93. Epub 2012 Jun 19.
8
Food and drug cues activate similar brain regions: a meta-analysis of functional MRI studies.食物和药物线索激活相似的大脑区域:功能磁共振成像研究的荟萃分析。
Physiol Behav. 2012 Jun 6;106(3):317-24. doi: 10.1016/j.physbeh.2012.03.009. Epub 2012 Mar 16.
9
Baseline factors associated with glycemic control and weight loss when exenatide twice daily is added to optimized insulin glargine in patients with type 2 diabetes.当每日两次给予艾塞那肽与优化的甘精胰岛素联合治疗时,与 2 型糖尿病患者血糖控制和体重减轻相关的基线因素。
Diabetes Care. 2012 May;35(5):955-8. doi: 10.2337/dc11-1434. Epub 2012 Mar 19.
10
fMRI reactivity to high-calorie food pictures predicts short- and long-term outcome in a weight-loss program.功能性磁共振成像(fMRI)对高热量食物图片的反应可预测减肥计划的短期和长期效果。
Neuroimage. 2012 Feb 1;59(3):2709-21. doi: 10.1016/j.neuroimage.2011.10.071.